Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CUE will decline by -3.03% over the next 2 Weeks and hit $27.87 by Friday, September 25, 2026. In that time frame, CUE's share price is expected to range between $24.92 and $30.74.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 25, 2026 | 24.92 | 27.87 | 30.74 |
| Sep 24, 2026 | 24.60 | 27.60 | 30.44 |
| Sep 23, 2026 | 24.80 | 27.88 | 30.74 |
| Sep 22, 2026 | 24.93 | 27.64 | 30.57 |
| Sep 21, 2026 | 23.64 | 26.46 | 29.24 |
| Sep 18, 2026 | 25.31 | 28.19 | 31.19 |
| Sep 17, 2026 | 25.00 | 27.92 | 30.70 |
| Sep 16, 2026 | 25.36 | 28.20 | 31.03 |
| Sep 15, 2026 | 25.20 | 27.96 | 30.68 |
| Sep 14, 2026 | 24.01 | 26.78 | 29.81 |
CUE shares rose +2.64% in Friday, September 11, 2026's trading session, rising from a previous close of $28.00 to move at $28.74. The stock demonstrated notable intraday movement (see CUE's key stats for a full breakdown), fluctuating between $27.63 and $28.94, a +4.74% trading range. While recent weeks have seen some volatility, CUE has managed to secure a +3.08% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 122.77K shares changing hands, 20.42K fewer than the previous session. This amounted to $3.53M in total market activity.
Will CUE Continue Its Upward Trend?
According to analyst ratings and projections for CUE, Cue Biopharma, Inc. shares are anticipated to increase by +6.51%, potentially reaching $30.74 per share by September 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for CUE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the CUE stock forecast, now is a good time to buy CUE stock because its current trading price is +3.12% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CUE covering social and institutional perspectives.
CUE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CUE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.06% to 52.73%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.77%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.81%, maintains a neutral outlook for the long term. Insights into CUE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cue Biopharma Short-Term Forecasts
CUE Forecast For Next 5 Days
Our algorithm anticipates Cue Biopharma (CUE) stock could hit $27.52 by Sep 18, 2026. This represents a -4.24% fall from today's price, following a -13.36% change over the past five days.
CUE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cue Biopharma, Inc. (CUE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $28.24, which would mean a -1.74% decrease from the current price of $28.74. Projections for this period range from a high of $36.99 to a low of $21.16.
CUE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cue Biopharma's price over the next three months point to a rise. CUE stock is expected to peak at $36.37 on Dec 10, 2026 after potentially dipping to $24.37 on Sep 15, 2026. On average, CUE is likely to trade around $31.31 in the coming 90 days.
Cue Biopharma Stock Forecast 2025
Based on our predictive models, Cue Biopharma (CUE) is expected to trade between $24.37 and $36.37 throughout 2026. This would result in an average price of $31.49, potentially offering investors a +9.57% return from current levels.
Cue Biopharma, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in September 2026. The price is predicted to move between $24.37 and $34.38, settling at an average of $28.68. This could translate to a -0.21% loss.
October 2026
Based on current market signals, Cue Biopharma, Inc. is projected to trend october 2026. We forecast a trading range from $27.12 to $36.09, with a likely average price of $31.73. Investors could expect a potential return of +10.40%.
November 2026
Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in November 2026. The expected range spans $25.11–$35.79, with an average target of $31.89. This represents a positive outlook and a possible gain of +10.96%.
December 2026
Analyzing established trends, Cue Biopharma, Inc. looks set to move in December 2026. Projections place the stock between $28.84 and $36.37, averaging around $32.48. This suggests a +13.01% gain from current levels.
January 2027
Market indicators suggest Cue Biopharma, Inc. could experience notable changes during January 2027. Prices could fluctuate within $28.28 to $35.49, with a midpoint forecast of $31.89. The stock might deliver a +10.96% gain.
February 2027
Forecasting for February 2027, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $26.10 and $35.57, averaging $30.62. This signals a positive trajectory with potential returns around +6.54%.
March 2027
According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in March 2027. The price is predicted to move between $29.62 and $37.90, settling at an average of $33.66. This could translate to a +17.12% gain.
April 2027
Based on current market signals, Cue Biopharma, Inc. is projected to trend april 2027. We forecast a trading range from $30.58 to $37.27, with a likely average price of $33.89. Investors could expect a potential return of +17.92%.
May 2027
Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in May 2027. The expected range spans $30.69–$37.88, with an average target of $34.33. This represents a positive outlook and a possible gain of +19.45%.
June 2027
Analyzing established trends, Cue Biopharma, Inc. looks set to move in June 2027. Projections place the stock between $30.05 and $37.19, averaging around $33.69. This suggests a +17.22% gain from current levels.
July 2027
Market indicators suggest Cue Biopharma, Inc. could experience notable changes during July 2027. Prices could fluctuate within $28.26 to $38.54, with a midpoint forecast of $32.82. The stock might deliver a +14.20% gain.
August 2027
Forecasting for August 2027, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $31.49 and $39.28, averaging $35.47. This signals a positive trajectory with potential returns around +23.42%.
September 2027
According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in September 2027. The price is predicted to move between $32.28 and $39.25, settling at an average of $35.65. This could translate to a +24.04% gain.
CUE's history of dividends and stock splits also plays a role in long-term investor confidence.